Andere Sprachen Roche Holding AG

Aktien

855167

CH0012032048

ROG

Pharmazeutika

Realtime-Estimate Cboe Europe Andere Börsenplätze 14:50:48 16.06.2025			% 5 Tage	% 1. Jan.
264,75 ^CHF	-1,84 %		-1,78 %	+3,72 %

13:49	Sarepta-Aktien stürzen nach zweitem Todesfall nach Gentherapiebehandlung ab	RE
13:32	Roche stoppt Einsatz von Elevidys nach zwei Todesfällen	DJ

Andere Sprachen

Sarepta shares tumble on second patient death after gene therapy treatment	13:49
North American Morning Briefing : Stock Futures Rise As Israel-Iran Conflict Enters Fourth Day	12:13
Prothena's Partner to Advance Potential Parkinson's Treatment to Phase 3 Development	09:58
Roche Pauses Commercial and Clinical Use of Elevidys After Fatal Liver Failures	09:40
La Fed revient dans le jeu	09:04
Bourse : Luca de Meo quitte Renault, OPA sur Santos, Mediobanca temporise	08:53
Principales informations avant-Bourse	08:44
Roche: moving towards phase 3 in Parkinson's disease	08:31
Roche: passi avanti per il trattamento del Parkinson	07:57
Roche avance sur son traitement contre la maladie de Parkinson	07:41
Roche to Advance Prasinezumab Into Phase 3 Trial for Early-Stage Parkinson's Disease	07:33
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease	07:16
Roche to Proceed with Phase Three Development of Investigational Drug for Parkinson's Disease	07:11
Roche To Advance Prasinezumab Into Phase III Development For Early-Stage Parkinson's Disease	07:03
Swiss stocks - Factors to watch on June 16	06:56
Sarepta reports second case of liver failure death after its gene therapy treatment	15.06.
Roche Updates Treatment Profile, Dosing Restrictions for Duchenne Muscular Dystrophy Treatment	15.06.
Roche cesse le traitement de certains patients atteint de dystrophie Duchenne	15.06.
Roche Provides Safety Update On Elevidys(TM) Gene Therapy For Duchenne Muscular Dystrophy In Non-Ambulatory Patients	15.06.
Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial	14.06.
Bourse Zurich: le SMI reste dans le rouge à l'approche de la mi-journée	13.06.
Bourse Zurich: le SMI sonné après l'attaque d'Israël en Iran	13.06.
Bourse Zurich: le SMI en vert, soutenu par ses poids lourds	12.06.
US FDA approves Nuvation Bio's rare lung cancer drug	11.06.
Roche obtient au Canada l'homologation de Piasky	11.06.